Sera Prognostics is a leading proteomic and bioinformatics company dedicated to improving the lives of women and babies through precision biomarker-based tests designed to enhance pregnancy care. Our vision is to deliver pivotal information to physicians early in pregnancy to help them to improve the health of their patients and reduce costs of healthcare delivery.
The PreTRM® Test reports to a physician the individualized risk of premature birth, enabling earlier proactive interventions in patients with higher risk. We're also developing a robust pipeline of innovative tests focused on other complications of pregnancy, including preeclampsia, gestational diabetes, growth restriction, and others.
Learn more about our values, culture, and open positions on our website.
Company Details
- Employees
- 79
- Founded
- -
- Address
- 2749 East Parleys Way, Salt Lake City,ut 84109,united States
- Phone
- 801-990-0520
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://seraprognostics.com/
- Keywords
- Maternal Fetal Medicine, Proteomics, Preterm Birth, Prematurity, Obstetrics, Pregnancy, preemie, premature birth.
- HQ
- Salt Lake City, UT
Sera Prognostics Questions
Sera Prognostics's helpline number is 801-990-0520
Sera Prognostics's website is https://seraprognostics.com/
Sera Prognostics's LinkedIn profile is https://www.linkedin.com/company/sera-prognostics
Sera Prognostics has
79 employees.
View email and phone details for 79
employees at Sera Prognostics.
Sera Prognostics's industry is
Biotechnology Research
Sera Prognostics's top competitors are
Dispersa,
Garuda Therapeutics,
Abcuro, Inc,
The Commons Project Foundation,
Subsense Inc.,
Nuvation Bio,
Variational Ai,
Enplusone Biosciences,
Aadi Bioscience, Inc,
Myriad Genetics.
Sera Prognostics's support email address is info@seraprognostics.com
Sera Prognostics's categories are Biotechnology Research
Sera Prognostics's founding year is 2008
